 |
 |
|
|
RESÚMENES NOVIEMBRE 2005 |
Basic Neuroscience & Pharmacology
(Haga un click en la información del journal para acceder al
resúmen)
Genotype-Phenotype Studies in Bipolar Disorder Showing Association Between the DAOA/G30 Locus and Persecutory Delusions: A First Step Toward a Molecular Genetic Classification of Psychiatric Phenotypes
Thomas G. Schulze, Stephanie Ohlraun, Piotr M. Czerski, Johannes
Schumacher, Layla Kassem, Monika Deschner, Magdalena Gross, Monja Tullius,
Vivien Heidmann, Svetlana Kovalenko, Rami Abou Jamra, Tim Becker, Anna
Leszczynska-Rodziewicz, Joanna Hauser, Thomas Illig, Norman Klopp, Stefan
Wellek, Sven Cichon, Fritz A. Henn, Francis J. McMahon, Wolfgang Maier, Peter
Propping, Markus M. Nöthen, Marcella Rietschel
Am
J Psychiatry 162:2101-2108, November 2005
Nature Neuroscience 8, 1491 - 1493 (2005)
Anxiety, memory
impairment, and locomotor dysfunction caused by a mutant thyroid hormone
receptor
César Venero, Ana Guadaño-Ferraz, Ana Isabel Herrero, Kristina
Nordström, Jimena Manzano, Gabriella Moreale de Escobar, Juan Bernal and Björn
Vennström
GENES & DEVELOPMENT
19:2152-2163, 2005
Daniel E. Feldman and Michael Brecht
Science, Vol 310, Issue 5749, 810-815 , 4 November 2005
White Matter Development During Childhood and Adolescence: A Cross-sectional Diffusion Tensor Imaging Study
Naama Barnea-Goraly, Vinod Menon, Mark Eckert, Leanne Tamm, Roland
Bammer, Asya Karchemskiy, Christopher C. Dant and Allan L. Reiss
Cerebral Cortex 2005 15(12):1848-1854
A double-blind, placebo- and positive-internal-controlled (alprazolam)
investigation of the cognitive and psychomotor profile of pregabalin in healthy
volunteers
Ian Hindmarch,
Leanne Trick and Fran Ridout
Psychopharmacology 2005; Volume 183, Number: 133
- 143
Intrinsic
Efficacy of Antipsychotics at Human D2, D3, and D4
Dopamine Receptors: Identification of the Clozapine Metabolite
N-Desmethylclozapine as a D2/D3 Partial Agonist
E. S. Burstein, J. Ma, S. Wong, Y. Gao, E. Pham, A. E. Knapp, N. R.
Nash, R. Olsson, R. E. Davis, U. Hacksell, D. M. Weiner, and M. R. Brann
Unequal Neuroprotection Afforded by the Acetylcholinesterase Inhibitors Galantamine, Donepezil, and Rivastigmine in SH-SY5Y Neuroblastoma Cells: Role of Nicotinic Receptors
Esperanza Arias, Sonia Gallego-Sandín, Mercedes Villarroya, Antonio G.
García, and Manuela G. López
Quetiapine
reverses the suppression of hippocampal neurogenesis caused by repeated
restraint stress
Can Luo, Haiyun Xu
and Xin-Min Li
Brain Research. Volume 1063, Issue 1, 23 November 2005, Pages 32-39
A
therapeutic role for cannabinoid CB1 receptor antagonists in major
depressive disorders
Jeffrey M. Witkin,
Eleni T. Tzavara, Richard J. Davis, Xia Li and George G. Nomikos
Trends
in Pharmacological Sciences. Volume 26, Issue 12, December 2005, Pages 609-617
Physiological
relevance of constitutive activity of 5-HT2A and 5-HT2C
receptors
Kelly A. Berg, John
A. Harvey, Umberto Spampinato and William P. Clarke
Trends
in Pharmacological Sciences. Volume 26, Issue 12, December 2005, Pages 625-630
Jessica E. Malberg
and Julie A. Blendy
Trends
in Pharmacological Sciences. Volume 26, Issue 12, December 2005, Pages 631-638
A neuroendocrine mechanism for sustaining fear
Jay Schulkin, Maria
A. Morgan and Jeffrey B. Rosen
Trends
in Neurosciences. Volume 28, Issue 12, December 2005, Pages 629-635
The Selective 5-HT2A Receptor Antagonist M100907
Enhances Antidepressant-Like Behavioral Effects of the SSRI Fluoxetine
Gerard J Marek, Raul Martin-Ruiz,
Allyson Abo and Francesc Artigas
Neuropsychopharmacology (2005) 30, 2205-2215
Cortical White Matter Microstructural Abnormalities in
Bipolar Disorder
John L Beyer, Warren D Taylor,
James R MacFall, Maragatha Kuchibhatla, Martha E Payne, James M Provenzale,
Frederick Cassidy and K Ranga R Krishnan
Neuropsychopharmacology (2005) 30, 2225-2229
James P. Herman,
Michelle M. Ostrander, Nancy K. Mueller and Helmer Figueiredo
David A. Morilak,
Gabe Barrera, David J. Echevarria, April S. Garcia, Angelica Hernandez, Shuaike
Ma and Corina O. Petre
Cholecystokinin
and endogenous opioid peptides: Interactive influence on pain, cognition, and
emotion
Andrea L.O. Hebb,
Jean-François Poulin, Sean P. Roach, Robert M. Zacharko and Guy Drolet
J Engl, M Laimer, A Niederwanger, M Kranebitter,
M Starzinger, M T Pedrini, W W Fleischhacker, J R Patsch
and C F Ebenbichler
Molecular Psychiatry (2005) 10, 1089–1096
A dopamine
transporter mutation associated with bipolar affective disorder causes
inhibition of transporter cell surface expression
S Horschitz, R Hummerich, T Lau, M Rietschel and
P Schloss
Molecular Psychiatry (2005) 10, 1104–1109
N Laurin, V L Misener, J Crosbie, A Ickowicz,
T Pathare, W Roberts, M Malone, R Tannock, R Schachar,
J L Kennedy and C L Barr
Molecular Psychiatry (2005) 10, 1117–1125
Are the effects of
the antidepressants amitriptyline, maprotiline, and fluoxetine on inhibitory
avoidance state-dependent?
M. Carmen Arenas,
Concepción Vinader-Caerols, Santiago Monleón, Ana J. Martos, Estrella Everss, Aránzazu
Ferrer-Añó and Andrés Parra
Behavioural
Brain Research. Volume 166, Issue 1, January 2006, Pages 150-158
CYP2D6
genotype and phenotype determination in a Mexican Mestizo population
Lopez M, Guerrero J,
Jung-Cook H, Alonso ME
Eur J Clin Pharmacol. 2005 Oct 26;:1-6
Tryptophan
hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder
and schizophrenia
De Luca V, Likhodi O, Van
Tol HH, Kennedy JL, Wong AH
Psychopharmacology (Berl). 2005 Oct 21;:1-5
Frances A Champagne
and James P Curley
Current Opinion in Neurobiology. Volume 15, Issue 6,
December 2005, Pages 704-709
Lisa A Parr,
Bridget M Waller and Jennifer Fugate
Current Opinion in Neurobiology. Volume 15, Issue 6,
December 2005, Pages 716-720
5-HT7
Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and
Sleep Pattern
Peter B. Hedlund,
Salvador Huitron-Resendiz, Steven J. Henriksen and J. Gregor Sutcliffe
Biological Psychiatry. Volume 58, Issue 10, 15 November 2005, Pages
831-837
Blunted Activation
in Orbitofrontal Cortex During Mania: A Functional Magnetic Resonance Imaging
Study
Lori L. Altshuler,
Susan Y. Bookheimer, Jennifer Townsend, Manuel A. Proenza, Naomi Eisenberger,
Fred Sabb, Jim Mintz and Mark S. Cohen
Biological Psychiatry. Volume 58, Issue 10, 15 November 2005, Pages
763-769
Neuropeptide Y
(NPY) shortens sleep latency but does not suppress ACTH and cortisol in
depressed patients and normal controls
Katja Held, Irina
Antonijevic, Harald Murck, Heike Kuenzel and Axel Steiger
Psychoneuroendocrinology. Volume 31, Issue 1, January 2006, Pages
100-107
Nature Neuroscience 8, 1760 - 1767 (2005)
Nature Neuroscience 8, 1776 - 1783 (2005)
Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information